Dai­ichi Sankyo dous­es a puz­zling re­port about an As­traZeneca buy­out of­fer

Here’s an­oth­er head scratch­er to con­sid­er on As­traZeneca.

The Lon­don-based phar­ma gi­ant re­port­ed­ly made a se­ri­ous pass at Japan’s Dai­ichi Sankyo last year, look­ing to buy the com­pa­ny and add it to their glob­al op­er­a­tions. But the re­port from Nikkei Busi­ness says that the Japan­ese com­pa­ny turned down the of­fer.

Reuters picked up the sto­ry, but couldn’t get any com­ments from the com­pa­nies. But soon af­ter Dai­ichi Sankyo de­cid­ed to squelch any ru­mors that may have been sparked. The com­pa­ny said in a state­ment:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER